Introducing Clinically Proven MelaFind®
New FDA-approved MelaFind® uses breakthrough technology to non-invasively and painlessly see below the skin's surface and objectively evaluate the 3-dimensional morphological disorganization of clinically atypical pigmented skin lesions. MelaFind® uses multi-spectral data capture and sophisticated computer algorithms to automatically acquire and analyze lesion data from under the skin surface. More information means more informed decisions when making difficult biopsy decisions.
Learn more about MelaFind® and Melanoma.